Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Institut Cancerologie de l'Ouest
Emory University
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Virginia Commonwealth University
Washington University School of Medicine
Yale University
Grupo Español Multidisciplinar de Melanoma
Thomas Jefferson University
Inova Health Care Services
Cedars-Sinai Medical Center
Taproot Health
Centre hospitalier de l'Université de Montréal (CHUM)
University of Southern California
Ohio State University Comprehensive Cancer Center
University Medical Center Groningen
Memorial Sloan Kettering Cancer Center
Eastern Cooperative Oncology Group
Quadriga Biosciences, Inc.
Grupo Español Multidisciplinar de Melanoma
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Northwestern University
Yale University
Eli Lilly and Company
DEKK-TEC, Inc.
Case Comprehensive Cancer Center
Celgene
Massachusetts General Hospital
Center Eugene Marquis
University of Pittsburgh
IGF Oncology, LLC
Novartis
Swiss Cancer Institute
British Columbia Cancer Agency
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
University Hospital, Lille
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Stanford University
BBB-Therapeutics B.V.
National Cancer Institute (NCI)
Angiochem Inc
GlaxoSmithKline
Norwegian University of Science and Technology
INSYS Therapeutics Inc
Memorial Sloan Kettering Cancer Center